ParaScale has announced their public cloud storage software, a cloud storage solution for enterprises to create their own public or private storage clouds. The software application runs in user space on any commodity hardware running standard linux and forms a highly scalable self-managing storage cloud with massive capacity and parallel throughput. Read more.
Mitrionics has announced a partnership agreement with Convey Computer Corporation, a pioneer in hybrid-core computing systems, regarding its Mitrion Accelerated Computing Platform and the Convey HC-1 server. Mitrionics will support its Mitrion Virtual Processor and Mitrion Software Development Kit on Convey’s HC-1 hybrid-core computers, and will demonstrate a Mitrion-accelerated Smith-Waterman algorithm running on the HC-1 in the Mitrionics booth # 1006 at SC09. Read more.
Eli Lilly has snagged AstraZeneca's head of drug discovery as its new research head. Jan Lundberg will join Lilly as early as January 2010. AstraZeneca has said that Lundberg is leaving immediately and will be replaced on an interim basis by Christer Koehler. Read more.
Tycrid Platform Technologies is launching the Prometheus Alliance, a limited collaboration alliance focused on developing high performance computing solutions for bioinformatics. The alliance site, www.prometheusalliance.org, will be live soon. Read more.
The NCI caBIG has released the Life Sciences Distribution 1.2 bundle of tools, a collection of open-source software tools that facilitates life sciences research by enabling the storage, collection, management, and analysis of a diverse set of biomedical research data types, including biospecimen data, microarray data and imaging data. In addition, LSD 1.2 includes tools for querying for and aggregating data from across the caGrid. All of the components of the LSD can be plugged into caGrid, and the tools may be downloaded and installed together or individually, depending on the needs of your institution. Read more.
Microchip Biotechnologies has raised $18.1m in Series B financing to fund the commercializaion of the Apollo 100 System, a sample prep system for Sanger DNA cycle sequencing and the development of the Apollo platform for next-gen sequencing and the emerging markets in DNA-based human identification and forensics. Read more.
NCI has released version 1.0 of the caIntegrator2 platform allows researchers to create custom translational study web portals for data query and analysis. These custom portals support the integration of clinical, microarray, and medical imaging data for querying, analysis and visualization, thus enabling multidisciplinary research. This first release of caIntegrator2 supports the integration and analysis of clinical data with expression data and copy number data from caArray (Affymetrix and Agilent platforms) and with images from the National Biomedical Imaging Archive (NBIA). In addition, data can be queried and analyzed via caGrid analytic services (Comparative Marker Selection, Principal Component Analysis and GISTIC at the time of this release) or via GenePattern. Analysis results can then be either viewed at GenePattern or downloaded from the caIntegrator2 portal. Read more.
GenomeQuest has announced a comprehensive and easy-to-use ChIP-Seq workflow solution available immediately as a web cloud service to researchers around the world. The ChIP-Seq method is described in this month’s Nature Methods journal, “Genome-wide measurements of protein-DNA interactions and transcriptomes are increasingly done by deep DNA sequencing methods (ChIP-Seq and RNA-Seq).” Reporting on tools, it continues, “Whereas early adopters necessarily developed their own custom computer code to analyze the first ChIP-Seq and RNA-Seq datasets, a new generation of more sophisticated algorithms and software tools are emerging to assist in the analysis phase of these projects.” Read more.
BioTrove is forming a wholly owned subsidiary named BIOCIUS Life Sciences to hold the assets of the RapidFire Business Unit. Upon completion of Life Technologies proposed acquisition of BioTrove, also announced today, BIOCIUS Life Sciences will be spun-out as an independent operating company. Read more.